FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

31696009: Human growth hormone recombinant (product)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    52956019 Human growth hormone recombinant en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    52957011 hGHr en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT core
    1187939015 Human growth hormone recombinant (product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    52956019 Human growth hormone recombinant en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    52956019 Human growth hormone recombinant en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    52957011 hGHr en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT core
    762859016 Human growth hormone recombinant (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    1187939015 Human growth hormone recombinant (product) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    1187939015 Human growth hormone recombinant (product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Human growth hormone recombinant (substance) Is a Product containing somatotropin (medicinal product) false Inferred relationship Existential restriction modifier (core metadata concept)
    Human growth hormone recombinant (substance) Is a Human growth hormone false Inferred relationship Existential restriction modifier (core metadata concept)
    Inbound Relationships Type Active Source Characteristic Refinability Group
    somatropine (efficacité biologique relative) 1,8 UI (0,6 mg), seringue préremplie de poudre et solvant pour solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Human growth hormone recombinant (substance) Inferred relationship Existential restriction modifier (core metadata concept)
    somatropine (efficacité biologique relative) 1,2 UI (0,4 mg), seringue préremplie de poudre et solvant pour solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Human growth hormone recombinant (substance) Inferred relationship Existential restriction modifier (core metadata concept)
    somatropine (efficacité biologique relative) 0,6 UI (0,2 mg), seringue préremplie de poudre et solvant pour solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Human growth hormone recombinant (substance) Inferred relationship Existential restriction modifier (core metadata concept)
    somatropine (rmc) 24 UI (8 mg), fiole de poudre et solvant pour solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Human growth hormone recombinant (substance) Inferred relationship Existential restriction modifier (core metadata concept)
    somatropine (efficacité biologique relative) 16 UI (5,33 mg), poudre et diluant pour injection avec nécessaire de reconstitution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Human growth hormone recombinant (substance) Inferred relationship Existential restriction modifier (core metadata concept)
    somatropine (efficacité biologique relative) 12 UI (4 mg), fiole de poudre et solvant pour solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Human growth hormone recombinant (substance) Inferred relationship Existential restriction modifier (core metadata concept)
    somatropine (efficacité biologique relative) 2,4 UI (0,8 mg), seringue préremplie de poudre et solvant pour solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Human growth hormone recombinant (substance) Inferred relationship Existential restriction modifier (core metadata concept)
    somatropine (efficacité biologique relative) 3 UI (1 mg), seringue préremplie de poudre et solvant pour solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Human growth hormone recombinant (substance) Inferred relationship Existential restriction modifier (core metadata concept)
    somatropine (efficacité biologique relative) 16 UI (5,33 mg), cartouche de poudre pour solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Human growth hormone recombinant (substance) Inferred relationship Existential restriction modifier (core metadata concept)
    somatropine (efficacité biologique relative) 16 UI (5,33 mg), fiole de poudre et solvant pour solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Human growth hormone recombinant (substance) Inferred relationship Existential restriction modifier (core metadata concept)
    somatropine (rmc) 10 UI (3,33 mg), fiole de poudre et solvant pour solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Human growth hormone recombinant (substance) Inferred relationship Existential restriction modifier (core metadata concept)
    somatropine (rmc) 4 UI (1,33 mg), fiole de poudre et solvant pour solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Human growth hormone recombinant (substance) Inferred relationship Existential restriction modifier (core metadata concept)
    somatropine (efficacité biologique relative) 4 UI (1,33 mg), fiole de poudre et solvant pour solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Human growth hormone recombinant (substance) Inferred relationship Existential restriction modifier (core metadata concept)
    somatropine (efficacité biologique relative) 36 UI (12 mg), cartouche de poudre pour solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Human growth hormone recombinant (substance) Inferred relationship Existential restriction modifier (core metadata concept)
    somatropine (efficacité biologique relative) 18 UI (6 mg), cartouche de poudre et solvant pour solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Human growth hormone recombinant (substance) Inferred relationship Existential restriction modifier (core metadata concept)
    somatropine (efficacité biologique relative) 36 UI (12 mg), cartouche de poudre et solvant pour solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Human growth hormone recombinant (substance) Inferred relationship Existential restriction modifier (core metadata concept)
    somatropine (efficacité biologique relative) 72 UI (24 mg), cartouche de poudre et solvant pour solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Human growth hormone recombinant (substance) Inferred relationship Existential restriction modifier (core metadata concept)
    somatropine (efficacité biologique relative) 3,6 UI (1,2 mg), seringue préremplie de poudre et solvant pour solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Human growth hormone recombinant (substance) Inferred relationship Existential restriction modifier (core metadata concept)
    somatropine (efficacité biologique relative) 4,2 UI (1,4 mg), seringue préremplie de poudre et solvant pour solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Human growth hormone recombinant (substance) Inferred relationship Existential restriction modifier (core metadata concept)
    somatropine (efficacité biologique relative) 4,8 UI (1,6 mg), seringue préremplie de poudre et solvant pour solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Human growth hormone recombinant (substance) Inferred relationship Existential restriction modifier (core metadata concept)
    somatropine (efficacité biologique relative) 5,4 UI (1,8 mg), seringue préremplie de poudre et solvant pour solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Human growth hormone recombinant (substance) Inferred relationship Existential restriction modifier (core metadata concept)
    somatropine (efficacité biologique relative) 6 UI (2 mg), seringue préremplie de poudre et solvant pour solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Human growth hormone recombinant (substance) Inferred relationship Existential restriction modifier (core metadata concept)
    somatropine (epr) 3,33 mg/mL, cartouche de 1,5 mL de solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Human growth hormone recombinant (substance) Inferred relationship Existential restriction modifier (core metadata concept)
    somatropine (epr) 6,66 mg/mL, cartouche de 1,5 mL de solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Human growth hormone recombinant (substance) Inferred relationship Existential restriction modifier (core metadata concept)
    somatropine (epr) 10 mg/mL, cartouche de 1,5 mL de solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Human growth hormone recombinant (substance) Inferred relationship Existential restriction modifier (core metadata concept)
    Somatotropin releasing factor-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Human growth hormone recombinant (substance) Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing somatropin (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Human growth hormone recombinant (substance) Inferred relationship Existential restriction modifier (core metadata concept)

    Reference Sets

    Concept inactivation indicator attribute value reference set (foundation metadata concept)

    SAME AS association reference set (foundation metadata concept)

    Back to Start